Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans - Biology of Blood and Marrow Transplantation
Mature B‐ and plasma‐cell flow cytometric analysis: A review of the impact of targeted therapy - Gao - Cytometry Part B: Clinical Cytometry - Wiley Online Library
Parallel CD19/CD20 CAR-Activated T-Cells Are More Effective for Refractory B-Cell Lymphoma In Vitro and In Vivo
Immunophenotyping of B Cells by Flow Cytometry | Bio-Rad
Immunophenotyping Utilizing 6 Color Flow Cytometry - Warde Medical Laboratory
CD79a surface staining: a useful marker of mature B cells - EXBIO Antibodies
Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma | Nature Medicine
of CD19 and CD20 expression during B cell development. CD19 expression... | Download Scientific Diagram
CD19 Antibody (Dako Omnis) | Agilent
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis | PLOS ONE
Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations
RB780 Mouse Anti-Human CD19
International Clinical Cytometry Society
Expression of CD5 and CD19 markers in B-cells of patients with chronic... | Download Scientific Diagram
CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO
Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications
Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus: Molecular Therapy - Methods & Clinical Development
Figures and data in A dynamic interaction between CD19 and the tetraspanin CD81 controls B cell co-receptor trafficking | eLife